Reinier Hernandez

Reinier Hernandez

University of Wisconsin-Madison

H-index: 33

North America-United States

About Reinier Hernandez

Reinier Hernandez, With an exceptional h-index of 33 and a recent h-index of 30 (since 2020), a distinguished researcher at University of Wisconsin-Madison,

His recent articles reflect a diverse array of research interests and contributions to the field:

PEG-FUD, A Promising Probe for Pulmonary Fibrosis, Targets the Pro-fibrotic Phase of Disease

[64Cu]Cu-PEG-FUD peptide for noninvasive and sensitive detection of murine pulmonary fibrosis

Impact of heterogeneity for mismatch repair activity on colon tumor development and therapeutic response

Development of an Engineered Single-Domain Antibody for Targeting MET in Non-Small Cell Lung Cancer

Myeloid-derived suppressor cells attenuate the antitumor efficacy of radiopharmaceutical therapy using 90Y-NM600 in combination with androgen deprivation therapy in murine …

Comparative Study of the Effect of Radiation Delivered by Lutetium-177 or Actinium-225 on Anti-GD2 Chimeric Antigen Receptor T Cell Viability and Functions

Fibroblast Activation ImmunoPET for Detection of Fibrosis Activity

Using Targeted Radiotherapy (TRT) to Drive Anti-Tumor Immune Response to Immunotherapies

Reinier Hernandez Information

University

Position

___

Citations(all)

3413

Citations(since 2020)

2221

Cited By

2181

hIndex(all)

33

hIndex(since 2020)

30

i10Index(all)

54

i10Index(since 2020)

52

Email

University Profile Page

Google Scholar

Top articles of Reinier Hernandez

PEG-FUD, A Promising Probe for Pulmonary Fibrosis, Targets the Pro-fibrotic Phase of Disease

2024/5

[64Cu]Cu-PEG-FUD peptide for noninvasive and sensitive detection of murine pulmonary fibrosis

Science Advances

2024/4/10

Impact of heterogeneity for mismatch repair activity on colon tumor development and therapeutic response

Cancer Research

2024/3/22

Reinier Hernandez
Reinier Hernandez

H-Index: 25

Development of an Engineered Single-Domain Antibody for Targeting MET in Non-Small Cell Lung Cancer

Bioconjugate Chemistry

2024/3/12

Reinier Hernandez
Reinier Hernandez

H-Index: 25

Myeloid-derived suppressor cells attenuate the antitumor efficacy of radiopharmaceutical therapy using 90Y-NM600 in combination with androgen deprivation therapy in murine …

Journal for Immunotherapy of Cancer

2024

Reinier Hernandez
Reinier Hernandez

H-Index: 25

Comparative Study of the Effect of Radiation Delivered by Lutetium-177 or Actinium-225 on Anti-GD2 Chimeric Antigen Receptor T Cell Viability and Functions

Cancers

2023/12/30

Reinier Hernandez
Reinier Hernandez

H-Index: 25

Krishanu Saha
Krishanu Saha

H-Index: 26

Fibroblast Activation ImmunoPET for Detection of Fibrosis Activity

2023/12/14

Using Targeted Radiotherapy (TRT) to Drive Anti-Tumor Immune Response to Immunotherapies

2023/12/14

PSMA-Targeting Ligands With Optimal Properties for Imaging and Therapy

2023/9/28

Targeting of Head and Neck Cancer by Radioiodinated CLR1404 in Murine Xenograft Tumor Models with Partial Volume Corrected Theranostic Dosimetry

Cancer Biotherapy & Radiopharmaceuticals

2023/9/1

Joseph Grudzinski
Joseph Grudzinski

H-Index: 8

Reinier Hernandez
Reinier Hernandez

H-Index: 25

FAP PET/CT imaging in radiation induced pulmonary fibrosis

2023/6/1

Specific Activity of 225Ac-PSMA Targeting Agents Impacts Biodistribution in Prostate Cancer Tumor Model

2023/6/1

Reinier Hernandez
Reinier Hernandez

H-Index: 25

Bromodomain inhibition potentiates 225Ac cytotoxicity in vitro

2023/6/1

Ohyun Kwon
Ohyun Kwon

H-Index: 1

Reinier Hernandez
Reinier Hernandez

H-Index: 25

64Cu-PEG-FUD for Non-Invasive Detection of Murine-Induced Pulmonary Fibrosis

2023/5

Dose, dose rate, and linear energy transfer influence tumor immunologic and DNA damage response following alpha-and beta-emitting radionuclides

Cancer Research

2023/4/4

Raghava N Sriramaneni
Raghava N Sriramaneni

H-Index: 9

Reinier Hernandez
Reinier Hernandez

H-Index: 25

Radionuclide-specific effects of90Y-,177Lu-, or225Ac-NM600 targeted radionuclide therapy on tumor immunomodulation and enhanced immunotherapy …

Cancer Research

2023/4/4

Impact of sequencing of immune checkpoint blockade and targeted radionuclide therapy on murine tumor response

Cancer Research

2023/4/4

Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination

Journal for Immunotherapy of Cancer

2023

Developments in combining targeted radionuclide therapies and immunotherapies for cancer treatment

2022/12/30

Reinier Hernandez
Reinier Hernandez

H-Index: 25

892 The novel telomerase-directed telomere-targeted anticancer agent 6-thio-dG (THIO) demonstrates potent activity and induces antitumor immunity in hepatocellular carcinoma …

2022/11/1

See List of Professors in Reinier Hernandez University(University of Wisconsin-Madison)